CJJD Jiuzhou 360 Total Asset Value of Company

CJJD (jiuzhou-drugstore.com) - company brandmark

China Jo-Jo Drugstores integrates digital medical services and retail outlets into a single ecosystem. This chart on GURU.Markets shows that total assets amount to 94.59. The business targets urban residents of the PRC, capitalizing on an aging population. Current growth is driven by telemedicine and the pharmacy network, while the market valuation already prices in regulatory challenges.

CJJD (China Jo-Jo Drugstores, Inc.) Company Total Assets history from 07/04/2022 to 03/04/2025

Analytical breakdowns and data insights for company jiuzhou-drugstore.com (CJJD)

- stock quotes and analyst forecast:
Share Price China Jo-Jo Drugstores, Inc.|CJJD - Price Target Chart
- market capitalization data:
Market Valuation China Jo-Jo Drugstores|CJJD - Enterprise Value
- issuer book value statistics:
Accounting Value of a Share China Jo-Jo Drugstores|CJJD - Book Capitalization|Market Capitalization to Book Value Ratio jiuzhou-drugstore.com|CJJD - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio China Jo-Jo Drugstores|CJJD - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio China Jo-Jo Drugstores, Inc.|CJJD - Company Aggregate Debts|Debts to Book Capitalization China Jo-Jo Drugstores|CJJD - Company Long-Term Debts|Company Current Liabilities China Jo-Jo Drugstores|Immediate Liquidity jiuzhou-drugstore.com
- net income and valuation multiples indicators:
CJJD - Net Profit
Fundamental valuation:China Jo-Jo Drugstores
Manufactured products of China Jo-Jo Drugstores Inc.

Stable demand for pharmaceutical products provides China Jo-Jo Drugstores (CJJD) with high macro-resilience, as reflected in the balance sheet asset history, where the current value of 94.59 is reverse-calculated via return on assets (ROA) to determine the total volume of resources. For the investor, this indicator serves as a measure of business scale, allowing them to filter out market noise and assess the efficiency of capital management within the defensive healthcare sector.

Direct competitors

Total Business Assets CVS|Aggregate Company Assets McKesson|Cencora Inc - Total Asset Value of Company|Company Total Assets CAH|HSIC (Henry Schein Dental) - Aggregate Asset Value|Company Total Assets PBH (Prestige Consumer Healthcare)|Company Total Assets Wellgistics Health, Inc. WGRX|YI - Aggregate Company Assets|Aggregate Asset Value RDGT (China Jo-Jo Drugstores, Inc.)|Universe Pharmacy (UPC) - Aggregate Company Assets|Cumulative Company Assets Biodexa Pharmaceuticals PLC|HKPD (Hong Kong Pharma Digital Ltd) - Company Total Assets|Company Total Assets usbimi.com|Company Total Assets WBA